India Pharma Outlook Team | Wednesday, 15 October 2025
Healthium Medtech, a global medical technology company with an expanding portfolio spanning surgical, post-surgical, advanced wound care, arthroscopy, and infection prevention, has entered into an exclusive partnership with Tisgenx, Inc.—a U.S.-based leader in bovine pericardial tissue patch manufacturing.
These tissue patches, essential in procedures like valve repair, vessel reconstruction, and other complex cardiovascular and soft tissue surgeries, will now be accessible to surgeons across India through this strategic alliance.
Under the terms of the agreement, Healthium has obtained exclusive distribution rights for Tisgenx’s products within the Indian market. This collaboration not only boosts Healthium’s presence in the cardiac care space but also aligns with its mission to offer innovation-driven and specialized medical solutions.
Tisgenx’s high-quality, dependable tissue patches complement Healthium’s commitment to delivering advanced, surgeon-focused products that support clinical decision-making and improve patient outcomes.
Also Read: India's Implant Market to Reach USD 5 Billion by FY28 on Strong Demand
Commenting on the partnership, Anish Bafna, CEO & MD of Healthium Medtech, stated that this collaboration significantly strengthens the company’s cardiac care portfolio and reflects its dedication to offering premium, best-in-class medical solutions tailored to the needs of Indian surgeons.
“We are proud to bring Tisgenx’s globally respected pericardial tissue patches to India through this exclusive partnership. As a homegrown medtech company, we remain focused on providing solutions that address the evolving needs of Indian surgeons and support them in their effort to deliver the best care for their patients,” he added.
